Mexican nationwide HAE prevalence for 2019 was estimated to be of 2024 total cases, corresponding to a rate of 0.805/50 000 inhabitants (CI 95% 0.805–0.808), with an estimated of 376 patients identified as C1-INH deficiency. This evidence concerns the gene SERPING1 and hyperinsulinemic hypoglycemia, familial, 4.